Found 419 bookmarks
Newest
The Benefits and Barriers to RFID Technology in Healthcare | HIMSS
The Benefits and Barriers to RFID Technology in Healthcare | HIMSS
The purpose of this paper is to explore the benefits and barriers of implementing radio-frequency identification (RFID) technology in the healthcare sector and to provide recommendations to overcome potential barriers.
·himss.org·
The Benefits and Barriers to RFID Technology in Healthcare | HIMSS
Opiate Addiction Therapies and HIV-1 Tat: Interactive Effects on Glial [Casup2+/sup]subi/sub, Oxyradical and Neuroinflammatory Chemokine Production and Correlative Neurotoxicity | Bentham Science
Opiate Addiction Therapies and HIV-1 Tat: Interactive Effects on Glial [Casup2+/sup]subi/sub, Oxyradical and Neuroinflammatory Chemokine Production and Correlative Neurotoxicity | Bentham Science
Few preclinical studies have compared the relative therapeutic efficacy of medications used to treat opiate addiction in relation to neuroAIDS. Here we com...
·eurekaselect.com·
Opiate Addiction Therapies and HIV-1 Tat: Interactive Effects on Glial [Casup2+/sup]subi/sub, Oxyradical and Neuroinflammatory Chemokine Production and Correlative Neurotoxicity | Bentham Science
HIV-1 Tat and Morphine Differentially Disrupt Pyramidal Cell Structure and Function and Spatial Learning in Hippocampal Area CA1: Continuous versus Interrupted Morphine Exposure | eNeuro
HIV-1 Tat and Morphine Differentially Disrupt Pyramidal Cell Structure and Function and Spatial Learning in Hippocampal Area CA1: Continuous versus Interrupted Morphine Exposure | eNeuro
About half the people infected with human immunodeficiency virus (HIV) have neurocognitive deficits that often include memory impairment and hippocampal deficits, which can be exacerbated by opioid abuse. To explore the effects of opioids and HIV on hippocampal CA1 pyramidal neuron structure and function, we induced HIV-1 transactivator of transcription (Tat) expression in transgenic mice for 14 d and co-administered time-release morphine or vehicle subcutaneous implants during the final 5 d (days 9–14) to establish steady-state morphine levels. Morphine was withheld from some ex vivo slices during recordings to begin to assess the initial pharmacokinetic consequences of opioid withdrawal. Tat expression reduced hippocampal CA1 pyramidal neuronal excitability at lower stimulating currents. Pyramidal cell firing rates were unaffected by continuous morphine exposure. Behaviorally, exposure to Tat or high dosages of morphine impaired spatial memory Exposure to Tat and steady-state levels of morphine appeared to have largely independent effects on pyramidal neuron structure and function, a response that is distinct from other vulnerable brain regions such as the striatum. By contrast, acutely withholding morphine (from morphine-tolerant ex vivo slices) revealed unique and selective neuroadaptive shifts in CA1 pyramidal neuronal excitability and dendritic plasticity, including some interactions with Tat. Collectively, the results show that opioid-HIV interactions in hippocampal area CA1 are more nuanced than previously assumed, and appear to vary depending on the outcome assessed and on the pharmacokinetics of morphine exposure.
·eneuro.org·
HIV-1 Tat and Morphine Differentially Disrupt Pyramidal Cell Structure and Function and Spatial Learning in Hippocampal Area CA1: Continuous versus Interrupted Morphine Exposure | eNeuro
How To Perform a Continuity Test for Electric Components with Multimeter?
How To Perform a Continuity Test for Electric Components with Multimeter?
Continuity Test, Why Do We Use Continuity Test? Procedure Of Continuity Test, Continuity Test For Capacitor, Continuity Test For Inductor, Homemade Continuity Tester, Continuity for Fuse, Switch, Cables, Resistor and other Electrical and electronic components and devices
·electricaltechnology.org·
How To Perform a Continuity Test for Electric Components with Multimeter?
G176212 Beckman Coulter 144003 P/ACE MDQ Capillary Electrophoresis System, Laser | eBay
G176212 Beckman Coulter 144003 P/ACE MDQ Capillary Electrophoresis System, Laser | eBay
Is there a Dock or Forklift available?. 95020 (408)886-3700. "The sale of this item may be subject to regulation by the U.S. Food and Drug Administration and state and local regulatory agencies.
·ebay.com·
G176212 Beckman Coulter 144003 P/ACE MDQ Capillary Electrophoresis System, Laser | eBay
Preventing Drug Misuse and Addiction: The Best Strategy | National Institute on Drug Abuse (NIDA)
Preventing Drug Misuse and Addiction: The Best Strategy | National Institute on Drug Abuse (NIDA)
Why is adolescence a critical time for preventing drug addiction? As noted previously, early use of drugs increases a person's chances of becoming addicted. Remember, drugs change the brain—and this can lead to addiction and other serious problems. So, preventing early use of drugs or alcohol may go a long way in reducing these risks.
·drugabuse.gov·
Preventing Drug Misuse and Addiction: The Best Strategy | National Institute on Drug Abuse (NIDA)
Why are cocaine users at risk for contracting HIV/AIDS and hepatitis? | National Institute on Drug Abuse (NIDA)
Why are cocaine users at risk for contracting HIV/AIDS and hepatitis? | National Institute on Drug Abuse (NIDA)
Drug intoxication and addiction can compromise judgment and decision-making and potentially lead to risky sexual behavior, including trading sex for drugs, and needle sharing. This increases a cocaine user’s risk for contracting infectious diseases such as HIV and hepatitis C (HCV).
·drugabuse.gov·
Why are cocaine users at risk for contracting HIV/AIDS and hepatitis? | National Institute on Drug Abuse (NIDA)
Screening and Assessment Tools Chart | National Institute on Drug Abuse (NIDA)
Screening and Assessment Tools Chart | National Institute on Drug Abuse (NIDA)
Choose evidence-based screening tools and assessment resource materials Tool Substance type Patient age How tool is administered Alcohol Drugs Adults Adolescents Self- administered Clinician-
·drugabuse.gov·
Screening and Assessment Tools Chart | National Institute on Drug Abuse (NIDA)
DASH - Dash Risk Checklist
DASH - Dash Risk Checklist
What is the aim of the DASH (2009) Risk Identification and Assessment Model? save and change lives through early identification, intervention and prevention identify risk and needs ensure an effective investigation create a common language across agencies to refer a case to risk management meetings such as MARAC enable information sharing inform decision making Who… Read more
·dashriskchecklist.co.uk·
DASH - Dash Risk Checklist
Chronic distress and the vulnerable host: a new target for HIV treatme | NBHIV
Chronic distress and the vulnerable host: a new target for HIV treatme | NBHIV
Chronic distress and the vulnerable host: a new target for HIV treatment and prevention? Carlo Contoreggi,1 George P Chrousos,2 Michele Di Mascio3 1Intramural Research Program (IRP), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Baltimore, MD, USA; 2Department of Pediatrics, Aghia Sophia Children’s Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece; 3AIDS Imaging Research Section, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA Abstract: Pathologic stress (distress) disturbs immune, cardiovascular, metabolic, and behavioral homeostasis. Individuals living with HIV and those at risk are vulnerable to stress disorders. Corticotropin-releasing hormone (CRH) is critical in neuroendocrine immune regulation. CRH, a neuropeptide, is distributed in the central and peripheral nervous systems and acts principally on CRH receptor type 1 (CRHR1). CRH in the brain modulates neuropsychiatric disorders. CRH and stress modulation of immunity is two-pronged; there is a direct action on hypothalamic–pituitary–adrenal secretion of glucocorticoids and through immune organ sympathetic innervation. CRH is a central and systemic proinflammatory cytokine. Glucocorticoids and their receptors have gene regulatory actions on viral replication and cause central and systemic immune suppression. CRH and stress activation contributes to central nervous system (CNS) viral entry important in HIV-associated neurocognitive disorders and HIV-associated dementia. CNS CRH overproduction short-circuits reward, executive, and emotional control, leading to addiction, cognitive impairment, and psychiatric comorbidity. CRHR1 is an important therapeutic target for medication development. CRHR1 antagonist clinical trials have focused on psychiatric disorders with little attention paid to neuroendocrine immune disorders. Studies of those with HIV and those at risk show that concurrent stress-related disorders contribute to higher morbidity and mortality; stress-related conditions, addiction, immune dysfunction, and comorbid psychiatric illness all increase HIV transmission. Neuropsychiatric disease, chronic inflammation, and substance abuse are endemic, and chronic distress is a pathologic factor. It is being understood that stress and CRH are fundamental to neuroendocrine immunity; therapeutic interventions with existing and novel agents hold promise for restoring homeostasis, reducing morbidity and mortality for those with HIV and possibly reducing future disease transmission. Keywords: corticotropin-releasing hormone, stress, neuroendocrine immunology, hypothalamic–pituitary–adrenal, cytokine, glucocorticoid resistance
·dovepress.com·
Chronic distress and the vulnerable host: a new target for HIV treatme | NBHIV
The state of application security: What the statistics tell us | CSO Online
The state of application security: What the statistics tell us | CSO Online
Companies are moving toward a DevSecOps approach to application development, but problems remain with security testing ownership and open-source code vulnerabilities.
·csoonline.com·
The state of application security: What the statistics tell us | CSO Online